This is Part 2 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

Innovative research is being performed in universities worldwide. There is a quest for knowledge, glory, and most importantly, helping the sick. On...

The San Diego Business Journal recently interviewed Scientist’s CEO Kevin Lustig about his latest side venture: “Bio, Tech and Beyond”, which is a...

We work with researchers from big and large pharma to discover new CROs and outsource drug discovery. Whether they have worked with a handful of...

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...

Outsourcing a project is often seen as an all or nothing proposition: either an entire project is outsourced or everything is kept in house. The...

This is Part 1 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

You’ve made the decision to outsource to a contract research organization, but you’re not sure where to start. Do you send it overseas for lower...

We found this on twitter today. It appears @mrgunn doesn’t really grasp the bigger picture of what we do if he thinks of @scientist_com as “just...

In two compelling presentations at the Bio-IT World Conference last week, Atul Butte and Steven Salzberg provided formidable advocacy for the...